Pankti A Gheewala1, Syed Tabish R Zaidi2, Matthew D Jose3, Luke Bereznicki2, Gregory M Peterson2, Ronald L Castelino4. 1. Division of Pharmacy, School of Medicine, Faculty of Health, University of Tasmania, Private Bag 26, Hobart, TAS, 7001, Australia. Pankti.Gheewala@utas.edu.au. 2. Division of Pharmacy, School of Medicine, Faculty of Health, University of Tasmania, Private Bag 26, Hobart, TAS, 7001, Australia. 3. School of Medicine, Faculty of Health, University of Tasmania, Hobart, TAS, 7000, Australia. 4. Sydney Nursing School, The University of Sydney, Sydney, NSW, 2050, Australia.
Abstract
BACKGROUND: Targeted screening interventions for chronic kidney disease (CKD) are increasingly being implemented in various community settings. However, the overall success of these programs is uncertain. Therefore, the aim of this review is to determine whether targeted screening is effective in detecting people with undiagnosed CKD. METHODS: We performed a systematic literature review, and included studies of targeted screening intervention implemented in any community-based setting. Studies were required to have targeted people aged ≥18 years, and multiple CKD risk factors from the following: diabetes, hypertension, cardiovascular disease and family history of kidney disease. The outcome measures were percentages of participants with positive screening test results and diagnosed with CKD at follow-up. RESULTS: Nine studies met the inclusion criteria. Eight studies reported the percentage of participants with positive screening test results, which ranged from 7 to 60.3%. Only two studies repeated the diagnostic tests to detect CKD, and confirmed the chronicity of CKD in 20.5 and 17.1% of screened participants. The most commonly used screening tests were albumin creatinine ratio (≥3.4 mg/mmol), and estimated glomerular filtration rate (eGFR) (<60 ml/min/1.73 m2). All studies classified CKD stage 3 and above based on eGFR alone. Characteristics of the interventions responsible for inconsistencies in the outcome measures included CKD risk factors targeted, and screening tests used to detect CKD. CONCLUSIONS: This systematic review found significant variation in the methods that were used to detect CKD, with the majority of studies reporting results based on only single albuminuria or eGFR values. Future targeted screening programs should appropriately use the 2012 KDIGO guidelines in order to detect CKD, which is necessary to determine the benefit of these programs when implemented in community-settings.
BACKGROUND: Targeted screening interventions for chronic kidney disease (CKD) are increasingly being implemented in various community settings. However, the overall success of these programs is uncertain. Therefore, the aim of this review is to determine whether targeted screening is effective in detecting people with undiagnosed CKD. METHODS: We performed a systematic literature review, and included studies of targeted screening intervention implemented in any community-based setting. Studies were required to have targeted people aged ≥18 years, and multiple CKD risk factors from the following: diabetes, hypertension, cardiovascular disease and family history of kidney disease. The outcome measures were percentages of participants with positive screening test results and diagnosed with CKD at follow-up. RESULTS: Nine studies met the inclusion criteria. Eight studies reported the percentage of participants with positive screening test results, which ranged from 7 to 60.3%. Only two studies repeated the diagnostic tests to detect CKD, and confirmed the chronicity of CKD in 20.5 and 17.1% of screened participants. The most commonly used screening tests were albumin creatinine ratio (≥3.4 mg/mmol), and estimated glomerular filtration rate (eGFR) (<60 ml/min/1.73 m2). All studies classified CKD stage 3 and above based on eGFR alone. Characteristics of the interventions responsible for inconsistencies in the outcome measures included CKD risk factors targeted, and screening tests used to detect CKD. CONCLUSIONS: This systematic review found significant variation in the methods that were used to detect CKD, with the majority of studies reporting results based on only single albuminuria or eGFR values. Future targeted screening programs should appropriately use the 2012 KDIGO guidelines in order to detect CKD, which is necessary to determine the benefit of these programs when implemented in community-settings.
Entities:
Keywords:
Chronic kidney disease; Community setting; Early detection; Effectiveness; Systematic review; Targeted screening
Authors: Conall M O'Seaghdha; Asya Lyass; Joseph M Massaro; James B Meigs; Josef Coresh; Ralph B D'Agostino; Brad C Astor; Caroline S Fox Journal: Am J Med Date: 2012-03 Impact factor: 4.965
Authors: Gregorio T Obrador; Guillermo García-García; Antonio R Villa; Ximena Rubilar; Nadia Olvera; Evangelina Ferreira; Margarita Virgen; José Alfonso Gutiérrez-Padilla; Melissa Plascencia-Alonso; Martha Mendoza-García; Salvador Plascencia-Pérez Journal: Kidney Int Suppl Date: 2010-03 Impact factor: 10.545
Authors: Claudine T Jurkovitz; Yang Qiu; Changchun Wang; David T Gilbertson; Wendy Weinstock Brown Journal: Am J Kidney Dis Date: 2008-04 Impact factor: 8.860
Authors: Pamela A Lopez-Vargas; Allison Tong; Premala Sureshkumar; David W Johnson; Jonathan C Craig Journal: Nephrology (Carlton) Date: 2013-09 Impact factor: 2.506
Authors: Carmen Expósito; Guillem Pera; Lluís Rodríguez; Ingrid Arteaga; Alba Martínez; Alba Alumà; María Doladé; Pere Torán; Llorenç Caballeria Journal: J Clin Med Date: 2019-09-04 Impact factor: 4.241
Authors: Pankti A Gheewala; Gregory M Peterson; Syed Tabish R Zaidi; Matthew D Jose; Ronald L Castelino Journal: BMC Public Health Date: 2018-03-20 Impact factor: 3.295
Authors: Pankti A Gheewala; Gregory M Peterson; Syed Tabish R Zaidi; Matthew D Jose; Ronald L Castelino Journal: Prev Chronic Dis Date: 2018-06-14 Impact factor: 2.830